Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
AC-CIF outpatient antibiotic trial for chemotherapy-induced fever
2025-520995-24-00Phase 3Authorised
- Sponsor
- Centre Hospitalier de Versailles
- Start
- Sep 2026
- Modality
- Classical Binding Small Molecules → Small Molecules, Covalent Small Molecules → Small Molecules, Nucleic Acid-Directed Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, open-label trial in febrile neutropenia (FN) and fever comparing Amoxicillin-clavulanate with Amoxicillin-clavulanate + ciprofloxacin (2 arms). Primary endpoint: Clinical success. Planned start Sep 2026; status: authorised.
02
Drugs
amoxicillin + clavulanateciprofloxacin
03
Conditions
febrile neutropenia (FN)fever
Beyond the preview
Go deeper on 2025-520995-24-00.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2025-520995-24-00.